Anti-proliferative SARMs were agonists in breast cancer cells with similar rank order for agonistic activity and anti-proliferative effects, indicating that highly potent androgens also possess robust anti-proliferative effects in MDA-MB-231-AR cells. The gene discussed is AR; the disease is breast carcinoma.